# Lyell Immunopharma, Inc.: Form 8-K, filed Jun 14, 2024

- Company: [Lyell Immunopharma, Inc.](/companies/lyel.md) (CIK 1806952)
- Form: 8-K
- Filed: 2024-06-14
- Accepted by EDGAR: Jun 14, 2024, 16:07 ET
- Period: 2024-06-14
- Accession: 0001193125-24-161601
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1806952/000119312524161601/d855288d8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1806952/000119312524161601/

## Items reported

- Item 5.07: Shareholder vote results

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1806952/000119312524161601/d855288d8k.htm

Filed Jun 14, 2024.
Source: SEC EDGAR, the filing index for accession 0001193125-24-161601. Last ingested by Listed: Nov 11, 2026, 03:59 ET. No prices; not investment advice.